CEO-TWO- laxative suppository 
Beutlich Pharmaceuticals, LLC

----------

CEO TWO

Active ingredients

Potassium bitartrate, 0.9 g

Sodium bicarbonate, 0.6 g

Purposes

Laxative

Uses

Warnings

For rectal use only

Keep out of reach of children

If swallowed, get medical help or contact a poison control center right away

Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor

Do not use this product if you are on a low salt diet unless directed by a doctor

Do not lubricate with mineral oil or petrolatum prior to rectal insertion

If you have noticed a sudden change in bowel habits that persists over a period of 2 weeks, consult a doctor before using a laxative

Laxative products should not  be used for a period longer than 1 week unless directed by a doctor

Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition.  Discontinue use and consult your doctor.

If pregnant or breast-feeding

ask a health professional before use

Directions

Adults and children 12 years of age and over:  rectal dosage is one suppository containing 0.6 gram of sodium bicarbonate and 0.9 gram of potassium bitartrate in a single daily dose

Children under 12 years of age:  consult a doctor

Detach one suppository from the strip; remove plastic wrapper.  Moisten suppository by placing it under a water tap for 30 seconds, or in a cup of water for at least 10 seconds, before insertion.  Insert rectally, bulb shape first, past largest diameter of suppository.  Retain suppository as long as possible (usually 10 to 30 minutes) before defecating.

Other information

Inactive ingredient

polyethylene glycol

Questions or comments?

1-800-238-8542

M-F:  8:00 a.m. - 4:30 p.m. ET

Prinicipal Display Panel - 54 count

NDC 0283-0808-54

CEO-TWO

Laxative Suppositories

Works within 30 Minutes!

Manufactured for:

Beutlich Pharmaceuticals, LLC

Bunnell, FL 32110

54 suppositories

Carton 54ct

CEO-TWO 
laxative suppository
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0283-0808
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POTASSIUM BITARTRATE (UNII: NPT6P8P3UU) (CARBON DIOXIDE - UNII:142M471B3J) CARBON DIOXIDE927 mg  in 3.7 g
SODIUM BICARBONATE (UNII: 8MDF5V39QO) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM BICARBONATE618 mg  in 3.7 g
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL 1450 (UNII: OJ4Z5Z32L4) 2155 mg  in 3.7 g
Product Characteristics
ColorwhiteScore    
ShapeBULLETSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0283-0808-022 in 1 BOX10/17/202309/30/2025
1NDC:0283-0808-015.7 g in 1 DOSE PACK; Type 0: Not a Combination Product
2NDC:0283-0808-466 in 1 BOX10/17/202309/30/2025
2NDC:0283-0808-015.7 g in 1 DOSE PACK; Type 0: Not a Combination Product
3NDC:0283-0808-5554 in 1 BOX10/17/202309/30/2025
3NDC:0283-0808-015.7 g in 1 DOSE PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00708/15/200809/30/2025
Labeler - Beutlich Pharmaceuticals, LLC (005209325)
Registrant - Beutlich Pharmaceuticals, LLC (005209325)
Establishment
NameAddressID/FEIBusiness Operations
Beutlich Pharmaceuticals, LLC005209325label(0283-0808) , pack(0283-0808)
Establishment
NameAddressID/FEIBusiness Operations
Speciality Pharma Manufacturing013957125manufacture(0283-0808)

Revised: 10/2023
Document Id: 087c799b-bb16-48ad-e063-6394a90a294c
Set id: d868de56-ac3b-4e44-8aa5-031661f0ac25
Version: 31
Effective Time: 20231024
 
Beutlich Pharmaceuticals, LLC